GlaxoSmithKline "deliberately" discontinued a widely-used asthma medication in order to reap profits and families suffered, ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its ...

Wellnex Life (ASX:WNX) managing director Zack Bozinovski admits that local investors don’t fully understand the power and ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

These include GlaxoSmithKline, though it is already looking to buy Novartis out of its joint venture in consumer health for around £8bn ($10.5bn). Others include Reckitt Benckiser, Procter ...

There were also strong gains for GSK's majority-owned HIV business ViiV Healthcare, up 19% to £1.5 billion, and anti-inflammatory medicines Nucala (mepolizumab) and Benlysta (belimumab).

Harvey Jones isn't having much fun playing the GSK share price game. The FTSE 100 pharmaceutical stock must work hard to make ...

In a report released today, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi (SNY – Research Report). The ...

Indian markets closed lower as gains in financial and oil & gas stocks were offset by consumer sector declines. Investors ...

News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants $1 Million to Karya for AI Upskilling in India Google.org awards USD 1 million to Karya, an Indian non-profit, to empower low-income ...

The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss ...